NU7026 100mg 100mg | Purity Not Available
Adooq Bioscience
NU7026 is a novel DNA-dependent protein kinase inhibitor that potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.
More Information Supplier PageNU7026 is a novel DNA-dependent protein kinase inhibitor that potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.
More Information Supplier PageNU7026 is a novel DNA-dependent protein kinase inhibitor that potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.
More Information Supplier PageUPF 1069 is a selective poly(ADP-ribose) polymerase (PARP) 2 inhibitor (IC50 values are 0.3 and 8.0 ??M for PARP-2 and PARP-1 respectively).
More Information Supplier PageUPF 1069 is a selective poly(ADP-ribose) polymerase (PARP) 2 inhibitor (IC50 values are 0.3 and 8.0 ??M for PARP-2 and PARP-1 respectively).
More Information Supplier PageApicidin is a a potent histone deacetylases (HDAC) inhibitor with potential anticancer activity.
More Information Supplier Page